Shengtai Pharmaceutical, Inc. (SGTI)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0000 - Volume
85,385 - Avg. Volume
85,385 - Market Cap (intraday)
-- - Beta (5Y Monthly) -1.27
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Shengtai Pharmaceutical, Inc., through its subsidiaries, engages in the manufacture and distribution of glucose and starch products in the People's Republic of China and internationally. The company provides pharmaceutical and medical grade products, including dextrose monohydrate, dextrose anhydrous, dextrin, and pharmaceutical grade cornstarch; and rough glucose, dextrose monohydrate oral, and food and beverage grade cornstarch for the food and beverage, and processing industries. It also offers other products comprising fibers, corn embryo, protein powder, mother liquid, and abamectin ointment. The company markets its products directly to healthcare institutions, medical supply companies, pharmaceutical companies, medical supply exporters, and food and beverage companies. Shengtai Pharmaceutical, Inc. was incorporated in 2004 and is based in Weifang, China.
--
Full Time Employees
June 30
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: SGTI
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SGTI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SGTI
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.70%
Return on Assets (ttm)
1.59%
Return on Equity (ttm)
-2.42%
Revenue (ttm)
221.39M
Net Income Avi to Common (ttm)
-1.55M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
38.1M
Total Debt/Equity (mrq)
283.82%
Levered Free Cash Flow (ttm)
-50.92M
Research Analysis: SGTI
Company Insights: SGTI
SGTI does not have Company Insights